PCSK-9 Inhibitors in a Real-World Setting and a Comparison between Alirocumab and Evolocumab in Heterozygous FH Patients

José Juan Ceballos-Macías, Carolina Lara-Sánchez, Jorge Flores-Real, Carlos Alberto Aguilar-Salinas, Guillermo Ortega-Gutiérrez, Joel Vargas-Sánchez, Ramón Madriz-Prado, Giuseppe Derosa, Hazel Rodríguez-Benítez, Ricardo Baltazar-Romero, Dante José Lopez-Mezquita

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'PCSK-9 Inhibitors in a Real-World Setting and a Comparison between Alirocumab and Evolocumab in Heterozygous FH Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences